Key result
Cholestyramine significantly decreased mean plasma warfarin levels and its hypoprothrombinemic effect, whereas an antacid mixture and psyllium colloid did not alter warfarin's pharmacologic action.
Why the study?
Do nonsystemic gastrointestinal drugs (cholestyramine, antacids, psyllium) alter the absorption and pharmacologic action of warfarin in normal subjects?
Do nonsystemic gastrointestinal drugs (cholestyramine, antacids, psyllium) alter the absorption and pharmacologic action of warfarin in normal subjects?
Cholestyramine significantly reduces the absorption and clinical effect of warfarin, indicating a clinically relevant drug interaction, whereas magnesium/aluminum antacids and psyllium do not.
Cholestyramine may reduce warfarin absorption and effect; leaves open clinical relevance in anticoagulated patients.
The absorption and pharmacologic action of warfarin may be influenced by such factors as gut motility, pH, solubility, and chemical binding. To investigate the possible interaction of warfarin with nonsystemic gastrointestinal drugs in clinical use, (1) cholestyramine, (2) an antacid mixture containing magnesium and aluminum hydroxide, and (3) psyllium hydrophyllic mucilloid were studied in 6 normal subjects. In a series of experiments average therapeutic doses of each drug were administered concurrently with a single oral dose of warfarin 40 mg. Cholestyramine was found to decrease significantly mean plasma warfarin levels and the hypoprothrombinemic effect of warfarin even after a 3 hour interval between ingestion of the two drugs. Neither the antacid nor psyllium colloid was found to alter plasma concentrations or pharmacologic action of warfarin. In vitro experiments demonstrated significant binding of warfarin to cholestyramine at a pH above its pKa of 5.5.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (1971) studied Healthy volunteers (n=6). Nonsystemic gastrointestinal drugs (cholestyramine, antacid mixture, psyllium) was evaluated on Plasma warfarin levels and hypoprothrombinemic effect. Cholestyramine significantly decreased mean plasma warfarin levels and its hypoprothrombinemic effect, whereas an antacid mixture and psyllium colloid did not alter warfarin's pharmacologic action.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: